ÖxmøÊgû@nWjú{zÂíwïÌ2002NÌ²¸ÉæéÆCú{A.

ZÔmÖîüføÊKAzÂíwïFè¤C{ÝÌ¤¿CzÂíÈÉÖOÅÏÉIÉÖxð·é¤¦ÅáQÉÈOªÝu³êCÏÉIÈÖxª³êÄ¢ééÆl¦çêÄ¢éÌÍCÖw±ðs¤ÌÉ{ÝÍí¸© 5÷É·¬È¢±Æªñ³êÄ¢Ôª©©é±ÆâfÃñVªÛØ³êÄ¢È¢±é1)DÔäçÌñ2) ÅÍC·SÇCSØ[ÇCÆCÖx@ÉÖ·é³çðó¯Ä¢È¢±Æs®¬C]²C³CAaCàCb§ÈÇÈÇªÌ«¾³³ÒÉ¨¢Äàp±µÄiµÄ¢éÌrÒªj«36.5÷C«29.5÷à

èC±êçÌiàÆÉì¬³ê½1998NÌpÌuÛãÃ]ÒÅÍ½Î±ÌQÌF¯xªñiÒâÖÒÒÌ½ßÌÖw±KChC£5) ÅÍCÕ°çêéDµ©µCpRNCu[3)ÆÄ AHCPR Ìr[4)ð

Éä×ÄLÓÉá¢D±êçÌ³ÒªÖ·é±°ãªêÊÌ³ÒÉÎµÄZÔÌÖÌAhoÆÍC¡ÃÌÜ¸êàÆà¢¤×«î{IÈ±ÆCXð·é¾¯ÅàÖ¦ðÅÆª¦³êÄ¢éi\PjDèCip±©Ö©ª¾³Ìisâ\ãÉÜÅÖWµÄ­éÌÅCKØÈÖw±ÍåÏdvÅ

°éøÊª

é±Õ°ãª 3 ªÔÌñíÉÈÕÈÖÌAhoCXð·éÆC½ÌAhoCXàµÈ¢êÉäéDòåwÅÍ1998N 5 ©çæ 2 àÈizÂ×C6 ÈãÌp±µ½Ö¦ª 2÷Á·íàÈjÉÖOðJÝµCzÂí¾³³Òð

éDÕ°ãÌ10ªÔxÉjR`ãÖÃ@ðÍ¶ßÆ·éåwa@Ê@¨æÑü@³ÒðSÁ¦éÆC½àîüµÈ¢êÉä×C6 ÖÆµÄCãÃãÖªKvÈêÌÝÈç¸CÖ

¦ª 9÷ã¸·éDÜ½ÖOÅjR`ãó]ÒÉÎµÄL­ÖxðsÁÄ«½DÖÃ@ðgpµ½êÉÍ16÷Ö¦ªã¸µC¡ãCÖOðÝuµCÖxðsÁÄ¢­ÛÉKvÈîñðTà·éDmKey words nCED

ü@Ì@ïâDPÌ@ïÉAhoCX·éÆøÊªéDµ½ªÁÄCOófÌ@ïðpµÄ

Öx#ÖO#Ç¯½ïãÖÃ@#Öw±§Ååï
ú{zÂíwïêåãzÂíêåãæAAªæQ B@@CNA@\PÕ°mêfmÖxmøÊÃô»¹ôµUñÈãÖV^iÒmÁ«Õ°ãÉæéñíÉÈÕÈAhoCXiRªjvs AhoCXÈµ

AHCPR

B÷

«Õ°ãÉæéÈÕÈÖAhoCXiA@ªjvs AhoCXÈµ«ÈÕÈAhoCXÉjR`ãÖÃ@ðÇÁ vsÈÕÈAhoCXÌÝCÜ½ÍCÈÕÈAhoCXÆvZ{

AHCPR
CochraneC÷F÷«­ÍÈÖxiáFÖOjvs îüÈµ«­ÍÈÖxÆjR`ãÖÃ@ vs­ÍÈÖxCÜ½ÍC­ÍÈÖxÆvZ{«ü@³ÒÉÎ·éÖAhoCXÆx vs xÈµ«iDwÉÎ·éÖAhoCXÆx vs ÊíÌPACÜ½ÍCîüÈµ

ARCPR

H÷Cochrane

H÷

AHCPR
AHCPRE÷G÷îüvfRg[QÆärµ½êÌeîüvfÉæéÖ¦ÌÁªD¢¸êàvwIÉLÓD
AHCPR: the Agency for Health Care Policy and Research (USA), Cochrane: the Cochrane Library (UK)i¶£ 5 æèøpjZÔÅà½­ÌãÃ]ÒªÖxðs¦Q Öðó]·éCµÈ¢É©©
µÄiAskjCüÎC½­ÌiÒÉ­«©¯ðs¤±ÆªÅ«Cíç¸CSõÉÖÌKv«ðAhoCX·éÖÒà¦é±ÆÉÈéD

R ¢ÅCÖðó]·é©Ç¤©
iAdvisejDüiÒÍÖ·é±Æðl¦Ä¢È¢iKiOS Öó]ÒÉÎµÄÖJðqËiAssessjCünlúj©çCÖðl¦Ä¢éiKinlúÆnÌxðs¤iAssistjD±êÍjR`£EõújCÖðÝÄ¢éiKiÀsújÆÈÇóÖÌÎªåÆÈèCjR`ãÖÃ@ÜÌèC»Ì¤¿Ì½l©ªÖÉ¬÷·éÆ³êT ÅãÉtH[AbvÌvæ±üàÜÜêéDüé6)DÖxÍiÒÉ¦ÌÖðßé¾ð§ÄéiArrangejCÆ³êÄ¢éD±Ìæ¤¯ÅÍÈ¢D»ÌÆ«ÍÖ¬÷ÆµÄÍ»êÈ

ÉCú{ÌãÃ»êÅàpÅ«éÖÌJnð­ÄàiÉÎ·éF¯âÓ¯ªÏ»µC1 Âix·éÌÉLøÈèð¦µÄ¢éDêûCÖ

ñ¾ÖÌiKÉÚ®³¹é±ÆàdvÈÚWÌðJnµ½êÂÅµÄÍCãÃ@ÖÅÌtH[ÌÙ©CC^[éDZÔÌÖAhoCXÍ±ÌiàÉLøÅéÆl¦çêéDlbgðpµ½·úÖxvOàJ­³êC¬ÊðB.

ÆÖp±ðtH[·éè@Æ°éæ¤ÉÈÁÄ«½8)DÖw±§Ååï

2000NÉÍ AHRQiÄú¶ÈÌºgDCC.

ÖxmÀÛ

Agency for Healthcare Research and QualityjÌiKµÉÍCujR`Ë¶vÆ¢¤ò¨É

Öw±KChCia Clinical Practice Guide­æégÌIË¶ÆuKµË¶vÆ¢¤¸_IË¶line for Treating Tobacco Use and Dependence,ÆªdÈÁÄ¢é½ßÉCÖ·é±Æª¢ïÅ2000N)7)ªì¬³ê½D±êÍ6,000Òð´¦éé±ÆàÀÅ_¶ÉîÃ­50ÈãÌ^AiVXðÀ{µ±±NCjR`Ë¶ÉÎµÄÍjR`ã½GrfXÉîÃ¢Äì¬³ê½àÌÅéDéDÖÃ@CKµË¶ÉÎµÄÍs®Ã@ðgÝí±ÌKChCÅÍC³Ü´ÜÈÛãÃ­ô¹Äs¤ÈwIÈÖ@ªÚ³êÄ¢éD±êÌñ¾ÌÙ©CÕ°»êÅvC}PAãªÖÜÅÌC¶ÁÆh¢äðµÄ½Î±ðâßéxð·éÛÌèª 5 ÂÌ A ÆµÄ¦³êã©çCjR`Ë¶ÉÎµÄÍCjR`K

P Ü¸iµÄ¢é³ÒðàêÈ­c¬Ä¢éDüâjR`pb`ðg¤±ÆÅCh­sõÈjR

ú{zÂíwïêåãzÂíêåãæAAªæQ B@@CNA@

CEE`£EÇóð}¦CärIyÉÖðißéÍÜÜê¸Czû³êéjR`ÍiÒªiãÉÈÁÄ¢éDÉæÁÄzû·éjR`æèÊí­ÊÅCÉâæÉq×½ AHRQ ÌKChCÉÁ½`ÅÀÛÌèð¦·DA)©ÈZxÌã¸ð¦µÀSÉgpÅ«éD
ú{ÅÍjR`KijRbgCOTCjAskFâfCÄCê_»YfiCOjZxªèCÂ\ÈçÎAR`jªèðs¤DÜ¸âfÅÍjR`Ë¶xðc¬·éDtÆjR`pb`ijR`l TTSCûòj¾¯ªgpµ¤éDiÆjR`ãÖÃ@ÜÌ¹pÍjR`ÌßèÛæÌÂ\«ªèë¯È

@[KXg[jR`Ë¶xeXg9)ªêÊ¤¦CiÅjR`ªø¦æ­zû³êé½ßIÅ

éªCuN°ã½ªÅ½Î±ðz¤©vÆÉòÜÌøÊª¸ã·é½ßCð¯È¯êÎÈç¢¤ÈPÈ¿âÅCÙÚ³mÉè·é±ÆªÅÈ¢DÜ¸ÍðzÁÄjR`ðæèüêéK

«éDN°¼ãÍ 1 úÌÅààÁÆàjR`µðCjR`pb`ÆjR`KÉ®SÉuèCN°Ìiv«·¦ÄµÜ¤±Æ©çÍ¶ßéD»ÌãCjRÌöxªjR`Ë¶Ì­³ð½fµÄ¢éDÄZxÌá¢ÔÅ`âÊðiKIÉ¸çµÄ¢­DêÉæÁC CO ZxªèÉÍX[J[CU[iBed­ÄÍCpb`ÆKÌ¹pàfont Ðjðp¢éÌªêÊIÅéDCO Zxªè¤éDSØ[ÇÌæ¤ÉjR`Ìe¿Å«»·élÆµÄ\³êé½ßCÖÌ®@t¯ÉLøOªÅéDA¸ªÂ\ÈçÎAR`jZxðéDµ©µÈªçCsÀè·SÇâSØ[ÇÌ}oIÉ\· NicCheck (Dynagene Ðjð¹p·«úCdÄÈs®¬ð¯ÎCS¾³³ÒÉàLéDøÉg¤±ÆªÅ«éDB)

AdviseFBÈbZ[Wðð¯CÍÁ«èÆ­­ÂlÉb)é¾³Éë³µ½ÆÍÓªKvÅSIË¶ÖÌÎFKµâð½ËÈÁ½ÖÌbZ[Wð`¦ÇSIË¶©ç­éivÌy¸ÉÍs®ÃéDãÃÖWÒÌuÅ«êÎÖµ½Ù¤ª¢¢@ð±ÜßÉÀsµiiµÈ¢Â«ð®¦CC

Å·ævâu{ð¸çµÈ³¢vÆ¢Á½B¿ði©ç»ç¹és®ðÀs·éjCÖÈ­¾ÍCÖÌ®@ÌáºÉÂÈªéÌÅâÎ

ÉÖµÄæÌ©ÊµðàÄéóµðAhoCX·Éð¯È¯êÎÈçÈ¢DéDC)

AssessFÖðl¦Ä¢éiÒð¯ÊµCÓvÌE)ArrangeF·úÉí½éüÍÌãÜµâkélðxµÄ¢­DÖÌÓvÌ§ÈtH[ªdvÆÈéDÖµ½±Æªæ©

È¢êÉÍC³çÉJèÔµÖÌbZ[WÁ½Æ´¶çêéæ¤èúIÉtH[µÄ¢ð`¦C®@t¯ðµÄ¢­Kvª­D³çÉÍC1 {ÅàÄiÉÂÈªé±ÆðD)éDAssistFiÌLQ«ðb·¾¯ÅÍÖs®ÍN±èÉ­¢½ßCÖÌøÊÈÇÌîñç©¶ßµÁ©èÓµÄ¨­±ÆàåØÅéDñâCLø«ª­ÀsÂ\ÆiÒª´¶éãÃÖWÒÌÂlÌóµÉ¶½ImÈAhoû@Ìñ¦ijR`ãÖÃ@âs®Ã@jªKCXÆCjR`ãÖÃ@Æs®Ã@Ì¹pÉævÅèCÖ¬÷¦ÍmÀÉãªéÆl¦çêéDa)éDjR`ãÖÃ@ÜÌgpFÖJnÉLø«ª­CeÕÉpÅ«éû@ÆµÄCjR`ãÖÃ@ªéDçâûoSÌÚGÊ©

òåwa@mÖOmÀÛçjR`ðXÉÌàÉzû³¹CÖÉÛµÖOÆÍCêÊOÅÌZÔÌw±ÅÍ

ÄN±é£EÇóðy¸µCÖðâ·édgÖªÞ¸©µ¢ÇáÉÎµÄÖÌ½ßÌêåÝÅI¡Ãðs¤OÅ

CEFéDjR`ãÖÃ@ÜÉÍjR`ÈO
ú{zÂíwïêåãzÂíêåãæAAªæQ B@@CNA@éDÅßÍC¢¬NÒÉÎ

\QÖOmÝè«©RfÃi©ïfÃjiòåwÅÍA@SªÉÝèj«Û¯fÃÆ¾mÉæÊ·éKvª éD¨«Jeðª¯éDiòåwÅÍJe in Jej«´Z\àÊÉª¯éDg©ïÖOiü@EOjCûièEÈµjhÌSó

ü@³ÒÍû¿ÌÝð¿·éDÈü@ÌêÍfÃïEû¿ÆàÉ¿D«ÊÌfÃgðÝ¯éDiòåwÅÍßãOÉÝèj«O³ÒEü@³ÒÆàÉÂ\ÅéD«ûÉÂ¢ÄÍC@àE@OðâíÈ¢D}PÖOi®S\ñ§jm¬·éÖ¡ÃðêåÆ·éOàJÝ³êÄ¢ÈéDÄfÍCjR`ãÖÃ@ðgp·é±Æª½¢½ß 1`2 TÔuÅÝèµCófÒÌó]éDÖOÌêÊIÈÝèÌðÆòåwa@âÖÌisóµÉ¶ÄñÌ\ñðsÁÄ¢ÌÖOÌófÌ¬êð\QC}PÉ¦·DÖ

éDî{IÉÍCjR`ãÖÃ@ªI¹µ½OÍ©RfÃÅ

é±Æ©çCÛ¯fÃÆÌ_æè 1 ãÌófðàÁÄCêófI¹¬ðð¯é½ßCßãÌOðÝèµCT 2ÆµÄ¨èiÖJnã 3`4 ª½¢jC»

ñ®S\ñ§ÅsÁÄ¢éDfÍót©çófÌãÌoßÏ@ÍSãÉä¾ËÄ¢éDI¹ÜÅñ45ªöxCÄfÍ20`30ªÌfÃÆú{zÂíwïêåãòåwa@Í2003N 4 æèSÙÖðÀzÂíêåãæAAªæQ B@@CNA@CEG

{µ½D±êÉæ§¿2003N 1 æèCSÙÖ

ÌÐïI¹¸ÆøÊIÈiÎôÉÖ·é¤C2003,ÉÈé|ÌAiEXâ|X^[Ìf¦Cu

pp5_20ïÈÇðsÁ½Æ±ëCÖOófÒª}
µ½Da@ÌÖ»ÆÖxª¨Ý¢ÇzÂµÄCÖ§íÒâÖ¬÷Òðâ·±ÆªÅ«CÐ¢ÄÍiÖA¾³Ì¸­ÉÂÈªéÆúÒµÄ¢éD3) Silagy C, Mant D, Fowler G et al: Nicotine replacement
therapy for smoking cessation. Database of abstracts ofreviews of eectiveness, in the Cochrane Library, Issue
2, update software, Oxford, 19984) Fiore MC, Bailey WC, Cohen Sj et al: Smokingcessation. clinical practice guideline No. 18. US Depart­
ment of Health and Human Services, Public HealthService, Agency for Health Care Policy and Research,1996 (AHCRP Publication No. 96_0692)

Ij5) Raw M, McNeill A, West R: Smoking cessation:

Nú{21ÌiÎôCNi@Ì{sCevidence based recommendations for the healthcare
system. BMJ 1999; 318: 182_185

WHO ½Î±K§ggÝðñÌáyC½Î±6) Prochaska JO, Velicer WF: The transtheoretical modelÅC½Î±x\¦ÌüùÈÇ½Î±ðéÂ«of health behavior change. American Journal of HealthâC¢ÌÌÓ¯Íå«­ÏíèÂÂéDúíÕ°ÌÅÌÖxCÖOÌÝuÉæéÏ
ÉIÈÖxðÊ¶ÄCiÖAzÂí¾³Ì¸­ðiµÄ¢«½¢àÌÅéD

Promotion 1997; 12: 38_487) A clinical practice guideline for treating tobacco use anddependence: a US Public Health Service report. thetobacco use and dependence clinical practice guideline
panel, sta, and consortium representatives. JAMA2000; 283: 3244_3254q1) Anti­Smoking¶£

Declaration:AqmessagefromtheJapanese Circulation Society. Circ J 2003; 67: 1_22) Ôä¾YCFrm¨F«¾³³ÒÌiÀÔÆiÉÎ·éÓ¯Dú¶J­Èw¤ïâàNÈw8) ´TqCR¾qFC^[lbgðgÁ½Öx335
DSÃàÈ 2001; 5: 328_9) Fagerstrom KO, Schneider NG: Measuring nicotine
dependence: a review of the Fagerstrom tolerance
questionnaire. J Behav Med 1989; 12: 159_182¤Æ½¬14NxEªS¤ñCiCEHú{zÂíwïêåãzÂíêåãæAAªæQ B@@CNA@